Predictors and Outcomes in Patients With Sickle Cell Disease

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2026

Conditions

Sickle Cell Disease

Trial Locations (2)

Methodist Adult Comprehensive Sickle Cell Center, Memphis

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

collaborator

Methodist Comprehensive Sickle Cell Center

UNKNOWN

collaborator

University of Memphis

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT03431935 - Predictors and Outcomes in Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter